Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

2(50.0%)

N/A

1(25.0%)

Phase 4

1(25.0%)

4Total

Phase 2(2)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06643741Recruiting

Non-Invasive Preeclampsia Screening and Biobank

Role: collaborator

NCT05248594Completed

Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

Role: collaborator

NCT05922124Phase 4Recruiting

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Role: collaborator

NCT06658574Phase 2Recruiting

Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients

Role: collaborator

NCT04614610Phase 2Unknown

Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis

Role: collaborator

NCT04343898Completed

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Role: collaborator

NCT02475954Not ApplicableCompleted

Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD)

Role: collaborator

NCT04684043Unknown

Prognostic Implications of Physiologic Investigation After Revascularization With Stent

Role: collaborator

All 8 trials loaded